Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 4/20 | 0.46 |
| ▸ | LMNA | P02545 | 3/20 | 0.46 |
| ▸ | RET | P07949 | 1/20 | 0.46 |
| ▸ | KDR | P35968 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | NPC1 | O15118 | 3/20 | 0.45 |
| ▸ | RAB9A | P51151 | 3/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.45 |
| ▸ | HPGD | P15428 | 2/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 6/20 | 0.45 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14438659 | 0.84 | MAPT (0.62) | TP53LMNAALDH1A1NPC1RAB9A | |
| SCHEMBL3784641 | 0.81 | MAPK14 (0.55) | BRD4TP53LMNARETKDR | |
| SCHEMBL28393556 | 0.80 | MAPT (0.65) | TP53LMNAALDH1A1NPC1RAB9A | |
| SCHEMBL28888396 | 0.75 | LMNA (0.64) | TP53LMNAALDH1A1NPC1RAB9A | |
| SCHEMBL31320738 | 0.75 | RAB9A (0.50) | TP53LMNAKDRNPC1RAB9A | |
| SCHEMBL14438661 | 0.74 | BRD4 (0.47) | BRD4RETKDRCYP3A4 | |
| SCHEMBL24393418 | 0.74 | TP53 (0.49) | TP53LMNAALDH1A1NPC1RAB9A | |
| SCHEMBL2718523 | 0.74 | CDK1 (0.59) | NPC1POLBMAPK1 | |
| SCHEMBL13057332 | 0.73 | FLT3 (0.49) | TP53LMNAALDH1A1NPC1RAB9A | |
| SCHEMBL28888394 | 0.73 | ALDH1A1 (0.66) | TP53LMNAALDH1A1NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10875880-B2 | Processes for preparing oligomers | SAREPTA THERAPEUTICS, INC. (US) | 2020-12-29 | — | — | US | disclosed |
| US-20200040020-A1 | PROCESSES FOR PREPARING OLIGOMERS | JPMORGAN CHASE BANK, N.A. AS ADMINISTRATIVE AGENT | 2020-02-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200040020-A1 | PROCESSES FOR PREPARING OLIGOMERS | NOP2, PCBP1, RNGTT | BRD4 4222/4885TP53 2210/4885LMNA 1421/4885 |
| US-10875880-B2 | Processes for preparing oligomers | NOP2, PCBP1, RNGTT | BRD4 4222/4885TP53 2210/4885LMNA 1421/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.